Targeted Injection Settings for HIV Prevention

Recruiting in Palo Alto (17 mi)

Overseen by Carl Latkin, PhD

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: Johns Hopkins Bloomberg School of Public Health

No Placebo Group

Trial Summary

What is the purpose of this trial?

Conduct a study of people who use drugs (PWUD) perceptions of and access to COVID-19 vaccines as well as reasons for vaccine hesitancy/barriers

Eligibility Criteria

This trial is for people who have used opioids in the last two weeks. It's focused on understanding their views on COVID-19 vaccines, access to these vaccines, and what might be stopping them from getting vaccinated. There are no specific exclusion criteria listed.

Inclusion Criteria

Opioid use in prior 2 weeks

Exclusion Criteria

Not applicable.

Treatment Details

Interventions

• Intervention test (Behavioral Intervention)

Trial Overview The study isn't testing a new drug or treatment. Instead, it's analyzing how people who inject drugs feel about COVID-19 vaccines and identifying any obstacles they face in getting vaccinated.

Participant Groups

Group I: Experimental Experimental Treatment 1 Intervention

behavioral intervention

Find a Clinic Near You

Research Locations Nearby Select from list below to view details:

Johns Hopkins Bloomberg School of Public Health Baltimore, MD

Who Is Running the Clinical Trial?

Johns Hopkins Bloomberg School of Public Health Lead Sponsor

National Institutes of Health (NIH) Collaborator

References